ASMB interim HBV data at EASL not impressing market, evidently: https://finance.yahoo.com/news/assembly-biosciences-presents-positive-interim-071000140.html The company thought these data were sufficiently consequential to hold an investor webcast this morning, but the stock is trading flat.